"My urine flow is poor”. Shane is 65-years old and complains of a 4 to 5-month history of progressive difficulty voiding. He finds it difficult to start.

Slides:



Advertisements
Similar presentations
Advances in the Management of BPH
Advertisements

Female and Male Cancers
HEALTH WISE FOR MEN Keep thy heart with all diligence, for out of it are the issues of life. Proverbs 4:23 (KJV) Bob White, AIM-IRS ABMTS Milwaukee, WI.
Case 7:John Case 7: John Understanding BPH From the Science to the Clinical Setting.
US TOO INTERNATIONAL, INC US TOO GREATER QUAD CITIES PROSTATE CANCER SUPPORT GROUP.
Case 1: George Case 1: George
MODULE 5 1/33 Case 5: Sam. MODULE 5 Case 5: Sam 2/33 Patient History  Sam is a 66 year old retired painter & construction worker.  He is distressed.
Breast and Prostate Cancer Prevention
Wake-up man… Can you guess who can get prostate cancer? Not you? Well, guess again… any male can get prostate cancer Hey, Smart Guy!
MODULE 5 1/26 Case 6: Anthony. MODULE 5 Case 6: Anthony 2/26 Patient History  Anthony is a 55-year old lawyer.  He has been suffering from voiding complaints.
MODULE 5 1/23 Case 9: Pierre. MODULE 5 Case 9: Pierre 2/23 Patient History  Pierre is 65 years of age who has suffered with benign prostatic hyperplasia.
AM Report 9/11/09 Prostate Cancer Julia Rauch. Disease Burden ~220,000 men were diagnosed with prostate cancer in 2007 ~1/6 men will receive the disagnosis.
Lower urinary tract symptoms (LUTS) in elderly males
Urology outpatients. Case 1 52 year old man Presents with increasing hesitancy of micturition Frequency Nocturia.
A PRACTICAL GUIDE TO PSA SCREENING Kendall Itoku, MD St. Louis Urological Surgeons.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
MODULE 5 1/46 Case 2: Troy. MODULE 5 Case 2: Troy 2/46 Patient History  Troy is a 59 year old retired school teacher who comes to you for his annual.
Prostate Cancer Education Seminar. What is the Prostate? A male sex gland The size of a walnut below the bladder and in front of the rectum Produces the.
Prostate Cancer: Education & Outreach Center for Cancer Prevention & Control Prevention and Health Promotion Administration Maryland Department of Health.
Understanding the Importance of Prostate Health Middle aged men
PROSTATE INFECTION Acute Bacterial Prostatitis
Prostate Cancer: Education & Outreach
Lower Urinary Tract Symptoms (LUTS) in men Kamal Patel GPST2.
2008. Causes of symptoms  Hyperplasia of epithelial and stromal components of prostate  Progressive obstruction of urinary outflow  Increased activity.
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
Professor Abhay Rane OBE
Prostate Cancer By: Kurt Rishel.
Dr Charles Chabert Urinary Symptoms &GreenLight Laser Prostatectomy.
Should I have that blood test for Prostate Cancer?
Prostate Cancer Case Presentation Shireen Siddiqui.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Benign Prostatic Hyperplasia
Urology Update Sanofi- Aventis
Asim Pasha.  Common condition seen in older men  Risk factors  1-age:  Around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms.
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
A GENERAL OVERVIEW OF PROSTATE CANCER. PROSTATE CANCER 101 SPONSORED BY THE CALIFORNIA STATE PROSTATE CANCER COALITION AND THE NATIONAL ALLIANCE OF STATE.
All about PSA (not Pharmaceutical Society of Australia)
Better Health. No Hassles. Prostate Cancer Month Sokan Hunro, PAC, MPH.
Prostate Pathology Emad Raddaoui, MD, FCAP, FASC.
PROSTATE CANCER PROSTATE CANCER What you should know about Prostate Cancer:  Prostate cancer is the most common type of cancer found in American men,
PCa Screening New Areas of Research Francesco Montorsi Milan.
Chapter 23: Cancer Prostate Cancer Brought to you by: Dusty R. Embery.
“I am a prostate cancer survivor and I am very thankful that the Men’s Health Clinic was started here on Standing Rock.” Del Lecompte, Fort Yates,
Men’s Health Prostate Awareness. Prostate Where is it? Where is it? What is a prostate? What is a prostate? What’s the issue? What’s the issue?
FACTS Prostate cancerProstate cancer is the most commonly diagnosed non-skin cancer. 80 percent of prostate cancers occur in men over the age of 65. Annually,
WHAT ON EARTH IS MOVEMBER? WHAT ON EARTH IS PROSTATE CANCER? ftjfj.
1 Ambassador Program Presentation Prevention & Early Detection PROSTATE CANCER.
Prostate Pathology. Prostate weighs 20 grams in normal adult Retroperitoneal organ,encircling the neck of bladder and urethra Devoid of a distinct capsule.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
MHPE Volunteer Resource ILLNESS PREVENTION Cancer and its prevention Tab 21.
1 Prostate Cancer. 2 Prostate Gland Muscular Walnut-sized gland Makes seminal fluid Muscles contract to push semen through the urethra Located directly.
Find out more at
PSA - Prostate Specific Antigen Bill Graden, M.D. BYU Student Health Center.
Pathology of the Urogenital Tract Male Genital Tract March 24, 2014.
Understanding Prostate Myths
DR. MOHAMMED ALTURKI COSULTANT UROLOGIST. Evaluation of the Urologic Patient The urologist has the ability to make the initial evaluation and diagnosis.
Men's Health By Dr. Ranil Perera Bincote Road surgery Patient Education Event.
COMMUNITY CONTINENCE ADVISORY SERVICE SHIRLEY BUDD CONTINENCE CLINICAL LEAD Continence Assessments 1.
Prostate Cancer Awareness In association with. What is Prostate Cancer?
ALI ABBAS BIO 1301 PROSTATE CANCER. QUICK FACTS ABOUT PROSTATE CANCER 1.Prostate Cancer is the most common type of cancer among men in the United States.
Chris Stubbings Uro-oncology CNS
Tumor markers 1111.
Case Study: Male Genitalia
Male Sexual Anatomy and Physiology
Prostate Cancer Dr .Gehan Mohamed.
PROSTATE CANCER.
Prostate Cancer Awareness
Presentation transcript:

"My urine flow is poor”

Shane is 65-years old and complains of a 4 to 5-month history of progressive difficulty voiding. He finds it difficult to start urinating and when he does go he has the feels as though he hasn't emptied his bladder completely. Consequently, after voiding he often feels as though he needs to urinate again. He denies any burning, urgency or urethral discharge.

WHAT IS THE LIKELY DDX?

DxT: poor urine flow + straining to void + frequency = BOO Bladder outlet obstruction Prostate cancer BPH Prostatitis Prostatic stones

Q2 WHAT ISSUES IN THE HISTORY OF A PATIENT PRESENTING WITH LUTS WOULD YOU SEEK TO SUPPORT A PARTICULAR DIAGNOSIS?

Is there a history of some weeks or months of bladder irritability (urinary frequency, nocturia)? Exclude urinary tract infection if the history is short or if dysuria is a major feature. Remember that acute urinary tract infection may be the first sign of prostate cancer Is there a history of difficulty stopping or starting urination, and is the strength of the urine stream deteriorating? These are cardinal symptoms of prostatic enlargement and may not necessarily indicate prostate cancer Is there any bone pain? Prostate cancer often spreads to the bones early, and bone pain may be the first symptom. The pain is usually localized, constant, and severe, and it may be worse with movement Is there any pain on ejaculation or blood in the ejaculate? These symptoms do not necessarily indicate any disease, but they may indicate prostatitis as well as prostate cancer Is the patient feeling generally unwell or tired, or has there been any weight loss, anorexia, thirst, memory disturbance, or confusion—perhaps noted by family or friends? These nonspecific features indicate possible systemic disease from cancer dissemination, renal failure, or hypercalcemia

Is there any lower limb numbness or weakness, difficulty walking, or problems with emptying the bowels or bladder? These features all suggest possible spinal cord problems and warrant rapid, complete investigation Family history Has anyone in your family ever had any prostate trouble? First- degree relatives are of particular interest Has anyone in your family undergone prostate surgery? Determine if this was for cancer or for BPH Does anyone in your family have regular injections for his prostate? Likely to be goserelin

Q3 WHAT RISK FACTORS ARE THOUGHT TO BE IMPORTANT IN THE DEVELOPMENT OF CARCINOMA OF THE PROSTATE?

Advanced age Family history – The presence of BRCA1 or BRCA2 mutations increases the risk of developing prostate cancer African-American ethnicity High dietary saturated fat intake, especially α-linolenic acid (found in red meat and butter), may be a risk factor and is crudely estimated to account for 10% to 15% of geographic differences in incidence. In contrast, genistein, an isoflavone found in soy, is believed to be protective (it inhibits 5α-reductase) – Low vegetable diet Vasectomy has been proposed as a risk factor, but a large analysis found no relationship, and the American Urological Association states that vasectomy is not associated with increased risk

Q4 WHAT CLINICAL EXAMINATION WOULD YOU PERFORM AND WHY?

Digital rectal examination (DRE) may reveal a nodule (50% are not carcinoma). Locally advanced cancer typically reveals a hard, nodular and irregular gland. Plus the usual….

All about PSA (not Pharmaceutical Society of Australia)

What is PSA?

Prostate Specific Antigen (PSA) is a glycoprotein actually not there to help screen for prostate pathology but to act physiologically in the ejaculate to liquefy the semen allowing sperm to break free from their seminal coagulum prison and swim freely; is likely to be instrumental in dissolving the cervical mucous via its proteolytic qualities, allowing the entry of sperm. PSA leaks into serum normally, and is present in the circulation of healthy men. Various prostate pathology will increase PSA eg. Prostatitis, BPH, Prostate CA etc. So PSA serum levels are used as a screening test.

What are some of the factors that can affect PSA levels?

PSA has not diurnal variation. Normal healthy males’ PSA levels don’t change. Ejaculation increases PSA levels, but they return to normal within 24 hours Some say riding pushbikes and motorbikes increases PSA too, but evidence remains inconclusive. Some drugs like cyclophosphamide and others can increase PSA too. DRE gives no significant change in PSA. BUT a vigorous prostate massage can produce a short-term 2-fold increase….Nothing sus. Cystoscopy, urethral catheterization, and TRUS do not tend to elevate the PSA level. Prostate needle biopsy increases PSA by a median of 7.9 ng/mL (6.5 times baseline value) within 5 minutes following the biopsy, this persists for 24 hours. Urinary retention increases PSA levels, but when relieved, they decrease 50% in hours. Acute prostatitis produces large increases in PSA, but the return to baseline depends on resolution of the infection, which may take 6-8 weeks or longer. PSA levels have been used to determine the duration of antimicrobial therapy in men with acute bacterial prostatitis. PSA half-life is days. After a biopsy, 2 to 4 weeks may need to elapse before the PSA returns to its original level.

What investigations would be most helpful and why?

DRE of course - Although PSA testing detects more cancers than DRE, a combination of the 2 methods is better: DRE detects more cancers at the PSA cutoff of 4.0 ng/mL, but this may not occur if the cutoff is lowered to 3.0 ng/mL. In men with prostate cancer whose PSA level was less than 4 ng/mL, normal DRE findings were present in 4-9%, while DRE findings were positive in 10-20%. When the PSA level was greater than 4 ng/mL, negative DRE results were found in % of patients, while positive DRE results were present in 42-72% of patients. TRUS Biopsy Cancer markers in general… Alkaline phosphatase Other Prostate cancer markers… Human glandular kallikrein–2 Prostate-specific membrane antigen Cell cycle inhibitor p27 Serum insulinlike growth factor

Few issues in medicine are as controversial as screening for prostate cancer. Briefly discuss why this is the case.

PSA testing it has a Positive predictive value of about 35% when the cutoff is about 3ng/mL (but we normally have cutoff at 4ng/mL PSA testing with a cutoff of 4 ng/mL has a sensitivity of %  implies that 20-30% of cancers are missed when only the PSA level is obtained. The sensitivity can be improved by lowering the cutoff or by monitoring PSA values so that a rise in PSA level of more than 20-25% per year or an increase of 0.75 ng/mL in a year would trigger performance of a biopsy regardless of the PSA value. The specificity of PSA at levels greater than 4 ng/mL is 60-70%. Specificity can be improved by using age-adjusted values, Men with low readings might still harbor dangerous cancers (gleason stage 5 might not produce PSA anymore), while those with high readings might be completely healthy. PSA, while normally at a steady serum concentration, can be affected by a lot of things (see above) Studies have shown that screening does not reduce the death rate in men 55 and over. NNT = 48 That’s 47 men who, in all likelihood, can no longer function sexually or stay out of the bathroom for long because the PSA test was justification for a urologist to jab it. More suited to monitor remission of prostate cancer etc

If screening is to be carried out which patients might be targeted and why?

Don’t screen for prostate cancer in men aged 75 years or older – they will die WITH CA rather than FROM it Screening when male and: 40yrs + family Hx of prostate CA or proven BRCA1/2 etc 50yrs + No family Hx recent onset of LUTS